Identification of hepatocellular carcinoma-related genes associated with macrophage differentiation based on bioinformatics analyses

References

• Cronin KA, Lake AJ, Scott S. Annual report to the nation on the status of cancer, part I: national cancer statistics. Cancer. 2018;124:2785–2800.
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Kanwal F. Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? Hepatology. 2014;60:1767–1775.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362(9399):1907–1917.
   PubMed Web of Science ®Google Scholar
• Lin Y, Xu J, Lan H. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J Hematol Oncol. 2019;12:76.
   PubMed Web of Science ®Google Scholar
• Biswas S, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010;11:889–896.
   PubMed Web of Science ®Google Scholar
• Wildes T, Dyson K, Francis C, et al. Immune escape after adoptive T cell therapy for malignant gliomas. Clin Cancer Res. 2020;26:5689–5700.
   PubMed Web of Science ®Google Scholar
• Ham S, Lima L, Chai E, et al. viaBreast cancer-derived exosomes alter macrophage polarization gp130/STAT3 signaling. Front Immunol. 2018;9:871.
   PubMed Web of Science ®Google Scholar
• Wolf-Dennen K, Gordon N, Kleinerman E. Exosomal communication by metastatic osteosarcoma cells modulates alveolar macrophages to an M2 tumor-promoting phenotype and inhibits tumoricidal functions. Oncoimmunology. 2020;9:1747677.
   PubMed Web of Science ®Google Scholar
• Li X, Lei Y, Wu M, et al. Regulation of macrophage activation and polarization by HCC-derived exosomal lncRNA TUC339. Int J Mol Sci. 2018;19:2958.
   PubMed Web of Science ®Google Scholar
• Pease N, Shephard M, Sertorio M, et al. DEK expression in breast cancer cells leads to the alternative activation of tumor associated macrophages. Cancers (Basel). 2020;12(7):1936.
   PubMed Web of Science ®Google Scholar
• Rhodes D, Yu J, Shanker K, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia (New York, N.Y.). 2004;6:1–6.
   PubMed Web of Science ®Google Scholar
• Ritchie M, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.
   PubMed Web of Science ®Google Scholar
• Wickham H. Ggplot2: elegant graphics for data analysis. Springer Publishing Company, Incorporated; 2009.
   Google Scholar
• Subramanian A, Tamayo P, Mootha V, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America. 2005;102:15545–15550.
   PubMed Web of Science ®Google Scholar
• Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77:e108–e10.
   PubMed Web of Science ®Google Scholar
• Mas V, Maluf D, Archer K, et al. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol Med (Cambridge, MA). 2009;15(3–4):85–94.
   PubMed Web of Science ®Google Scholar
• Roessler S, Jia H, Budhu A, et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res. 2010;70(24):10202–10212.
   PubMed Web of Science ®Google Scholar
• Wurmbach E, Chen Y, Khitrov G, et al. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology. 2007;45:938–947.
   PubMed Web of Science ®Google Scholar
• Xi J, Huang Q, Wang L, et al. miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy. Oncogene. 2018;37:3151–3165.
   PubMed Web of Science ®Google Scholar
• Pallocca M, Angeli D, Palombo F, et al. Combinations of immuno-checkpoint inhibitors predictive biomarkers only marginally improve their individual accuracy. J Transl Med. 2019;17:131.
   PubMed Web of Science ®Google Scholar
• Chamoto K, Hatae R, Honjo T. Current issues and perspectives in PD-1 blockade cancer immunotherapy. Int J Clin Oncol. 2020;25:790–800.
   PubMed Web of Science ®Google Scholar
• Lv J, Chen F, Liu C, et al. Zoledronic acid inhibits thyroid cancer stemness and metastasis by repressing M2-like tumor-associated macrophages induced Wnt/β-catenin pathway. Life Sci. 2020;256:117925.
   PubMed Web of Science ®Google Scholar
• Tian X, Wu Y, Yang Y, et al. Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt/β-catenin signaling. Mol Oncol. 2020;14:462–483.
   PubMed Web of Science ®Google Scholar
• Donadon M, Torzilli G, Cortese N, et al. Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis. J Exp Med. 2020;217. DOI:10.1084/jem.20191847
   PubMed Web of Science ®Google Scholar
• Xia H, Li S, Li X, et al. Autophagic adaptation to oxidative stress alters peritoneal residential macrophage survival and ovarian cancer metastasis. JCI Insight. 2020;5. DOI:10.1172/jci.insight.141115
   Web of Science ®Google Scholar
• Shiau D, Kuo W, Davuluri G, et al. Hepatocellular carcinoma-derived high mobility group box 1 triggers M2 macrophage polarization via a TLR2/NOX2/autophagy axis. Sci Rep. 2020;10:13582.
   PubMed Web of Science ®Google Scholar
• Kaneko T, Amano M, Maeda A, et al. Identification of calponin as a novel substrate of Rho-kinase. Biochem Biophys Res Commun. 2000;273:110–116.
   PubMed Web of Science ®Google Scholar
• Amano M, Nakayama M, Kaibuchi K. Rho-kinase/ROCK: a key regulator of the cytoskeleton and cell polarity. Cytoskeleton (Hoboken, NJ). 2010;67:545–554.
   PubMed Web of Science ®Google Scholar
• Ye Y, Zhang R, Feng H. Fibronectin promotes tumor cells growth and drugs resistance through a CDC42-YAP-dependent signaling pathway in colorectal cancer. Cell Biol Int. 2020;44:1840–1849.
   Web of Science ®Google Scholar
• Pulecio J, Petrovic J, Prete F, et al. Cdc42-mediated MTOC polarization in dendritic cells controls targeted delivery of cytokines at the immune synapse. J Exp Med. 2010;207:2719–2732.
   PubMed Web of Science ®Google Scholar
• Lu W, Zhilan L. Degradation of Cdc42 in response to lipid antigen variants controls immune responses of iNKT cells via regulating direction of IL4 secretion. The 12th National Congress of immunology.
   Google Scholar
• Piñeiro Fernández J, Luddy K, Harmon C, et al. Hepatic tumor microenvironments and effects on NK cell phenotype and function. Int J Mol Sci. 2019;20:4131.
   PubMed Web of Science ®Google Scholar
• Mantovani S, Oliviero B, Varchetta S, et al. Natural killer cell responses in hepatocellular carcinoma: implications for novel immunotherapeutic approaches. Cancers (Basel). 2020;12:926.
   Web of Science ®Google Scholar
• Sadeghi Rad H, Monkman J, Warkiani M, et al. Understanding the tumor microenvironment for effective immunotherapy. Med Res Rev. 2020;1:25.
   PubMed Web of Science ®Google Scholar
• Johnson D, Burtness B, Leemans C, et al. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6:92.
   PubMed Web of Science ®Google Scholar
• Kumar S, Joga S, Biswas B, et al. Immune checkpoint inhibitors in advanced non-small cell lung cancer: a metacentric experience from India. Curr Probl Cancer. 2020;44:100549.
   PubMed Web of Science ®Google Scholar
• Lai E, Astara G, Ziranu P, et al. Introducing immunotherapy for advanced hepatocellular carcinoma patients: too early or too fast? Critical Reviews in Oncology/hematology. 2020;157:103167.
   PubMed Web of Science ®Google Scholar
• Albarel F, Castinetti F, Brue T. MANAGEMENT OF ENDOCRINE DISEASE: immune check point inhibitors-induced hypophysitis. Eur J Endocrinol. 2019;181:R107–R18.
   PubMedGoogle Scholar
• Sharma A, Johnson A. Exosome DNA: critical regulator of tumor immunity and a diagnostic biomarker. J Cell Physiol. 2020;235:1921–1932.
   PubMed Web of Science ®Google Scholar
• Lv J, Feng Z, Chen F, et al. M2-like tumor-associated macrophages-secreted Wnt1 and Wnt3a promotes dedifferentiation and metastasis via activating β-catenin pathway in thyroid cancer. Mol Carcinog. 2020.
   Web of Science ®Google Scholar
• Chen Z, Hua S. Transcription factor-mediated signaling pathways’ contribution to the pathology of acute lung injury and acute respiratory distress syndrome. Am J Transl Res. 2020;12:5608–5618.
   PubMed Web of Science ®Google Scholar
• Yuan C, Yang D, Ma J, et al. Modulation of Wnt/β-catenin signaling in IL-17A-mediated macrophage polarization of RAW264.7. cells. 2020;53:e9488.
   Google Scholar
• Feng Y, Liang Y, Zhu X, et al. The signaling protein Wnt5a promotes TGFβ1-mediated macrophage polarization and kidney fibrosis by inducing the transcriptional regulators Yap/Taz. The Journal of Biological Chemistry. 2018;293:19290–19302.
   PubMed Web of Science ®Google Scholar
• Han B, Zhao J, Wang W, et al. Cdc42 promotes schwann cell proliferation and migration through Wnt/β-catenin and p38 MAPK signaling pathway after sciatic nerve injury. Neurochem Res. 2017;42:1317–1324.
   PubMed Web of Science ®Google Scholar
• Schlessinger K, McManus E, Hall A. Cdc42 and noncanonical Wnt signal transduction pathways cooperate to promote cell polarity. J Cell Biol. 2007;178:355–361.
   PubMed Web of Science ®Google Scholar